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Biosynthesis and NMR-studies of a double transmembrane
domain from the Y4 receptor, a human GPCR
Abstract
The human Y4 receptor, a class A G-protein coupled receptor (GPCR) primarily targeted by the
pancreatic polypeptide (PP), is involved in a large number of physiologically important functions. This
paper investigates a Y4 receptor fragment (N-TM1-TM2) comprising the N-terminal domain, the first
two transmembrane (TM) helices and the first extracellular loop followed by a (His)6 tag, and addresses
synthetic problems encountered when recombinantly producing such fragments from GPCRs in
Escherichia coli. Rigorous purification and usage of the optimized detergent mixture 28 mM
dodecylphosphocholine (DPC)/118 mM%
1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (LPPG) resulted in high quality
TROSY spectra indicating protein conformational homogeneity. Almost complete assignment of the
backbone, including all TM residue resonances was obtained. Data on internal backbone dynamics
revealed a high secondary structure content for N-TM1-TM2. Secondary chemical shifts and sequential
amide proton nuclear Overhauser effects defined the TM helices. Interestingly, the properties of the
N-terminal domain of this large fragment are highly similar to those determined on the isolated
N-terminal domain in the presence of DPC micelles.
Biosynthesis and NMR-studies of a double 
transmembrane domain from the Y4 receptor, a human 
GPCR  
 
4.1 Introduction 
Membrane proteins are the most abundant class of proteins in prokaryotic and 
eukaryotic organisms and account for 20-30% of the total genome 1; 2. Amongst these, G-
protein coupled receptors (GPCRs) constitute the largest membrane protein family 3, 
accounting for 2% of the genome 4. GPCRs play critical roles in molecular recognition 
and signal transduction and are among the most pursued pharmaceutical targets 5. Around 
30% of all marketed prescription drugs act on GPCRs, making this class of proteins a 
most successful therapeutic target 6. 
Despite their prime biological importance surprisingly little structural information is 
available due to the tremendous difficulties encountered in producing GPCRs in active 
form and the problems associated with their structural study by crystallography or NMR. 
Recent advances in the expression and purification of membrane proteins have been 
described for various expression hosts, for example: Escherichia coli 7; 8; 9, yeast 10; 11, 
insect cells 12, mammalian cells 13; 14 and cell-free systems 15. However, from 
approximately 1000 known GPCRs, only five high-resolution 3-D structures of two 
distinct receptor types have been reported: bovine rhodopsin 16 and opsin 17, squid 
rhodopsin 18, the human β2-adrenergic receptor 19; 20 and the turkey β1-adrenergic 
receptor 21.  
As long as structural studies on intact GPCRs remain complicated by technical 
difficulties, the study of fragments of these receptors can deliver potentially valuable 
insights into the structure and function of these molecules. Studies on fragments may also 
help to establish methods required to tackle more complex systems, in particular by 
providing information concerning protein-lipid interactions. While fragments of domains 
from soluble proteins are often not stably folded, in integral membrane proteins the 
additional stabilizing interactions that occur between TM helices and the surrounding 
lipids can result in stretches of the polypeptide that are conformationally defined and can 
be studied on their own. In 1990 Popot proposed a two-step model, the so-called 
partitioning-folding model, to describe assembly of membrane proteins in vivo 22; 23, that 
was later extended by White 24: Initially, partitioning of the protein into the water-
membrane interface results in formation of secondary structure. Interactions of the 
hydrophobic side chains with the surrounding lipid environment then lead to insertion of 
the transmembrane domains into the membrane interior. Finally, the functional protein is 
assembled via formation of the proper helix-helix contacts. According to this model the 
transmembrane domains can be thought of as independent folding units and be studied 
separately. A large body of literature supports the basic assumption of the model: For 
example, proteolysis of membrane proteins resulted in fragments containing entire TM 
sequences 25, and chemically or recombinantly synthesized TM peptides spontaneously 
assembled thereby rescuing receptor activity 26; 27; 28; 29. Finally, peptides corresponding to 
the N and C terminus 30; 31, loop domains 32; 33; 34; 35 and transmembrane domains 33; 34; 36; 
37; 38; 39; 40; 41; 42 from GPCRs have been found to fold to distinct secondary structures 
which in certain cases resembled the structures of the corresponding regions of the intact 
receptor.  
TM domains usually contain about 25 residues 43; 44, therefore double-TM constructs 
in phospholipid micelles should be applicable to high-resolution NMR study. Though 
much effort has been devoted to the study of membrane proteins both by NMR and 
crystallography, so far few membrane protein structures have been determined by the 
former technique, amongst these the F1,F0-ATPase 45, the bacterial mercury transport 
membrane protein 46 and the human glycine receptor 47, all of which comprise two TM 
domains. One reason why there are still so few NMR studies of larger membrane proteins 
published is due to the fact that sufficient quantities of labeled protein are often not 
available for the required trials to optimize sample conditions. In the current study we 
therefore tried to optimize expression of a double transmembrane fragment of the NY-4 
receptor. We consider that the solutions to problems addressed in this work might be 
generally applicable to researchers working on polytopic membrane polypeptides.  
X-ray diffraction analysis of integral membrane proteins requires high quality single 
crystals. In contrast NMR in solution and the solid state is independent of protein 
crystallization and provides complementary information to that obtained by X-ray 
investigations 48; 49; 50; 51; 52; 53; 54. However, NMR studies on GPCRs or large fragments of 
these integral membrane proteins require isotopic enrichment. This requirement makes 
production impossible in expression systems such as mammalian hosts, because 
deuteration has not been achieved to date. Moreover, membrane proteins must be studied 
in a membrane-like environment such as detergent micelles. The concomitant increase in 
molecular weight as a consequence of micelle incorporation results in a dramatic 
decrease in spectral quality. In addition, slow conformational exchange processes lead to 
additional line-broadening. This has led to the frequently encountered experience that 
signals from the TM regions of membrane proteins remain invisible 54. The lack of 
availability of fully deuterated detergents, compounds the technical difficulty of 
obtaining high resolution spectra for GPCRs or their fragments in micelles. 
 
 
Figure 1: “Snake”-plot type presentation of the human Y4 receptor. The plot was modified from a 
download from the GPCR.org website. The part of the receptor that has been expressed in this work 
is shaded in gray. Note that the expressed polypeptide additionally contains a C-terminal (His)6 tag. 
The omitted sequences for parts of the N terminus and the E1 loop are indicated separately in the 
figure. 
 
Herein, we report on the expression and purification of a 115-residue (121 residues 
with the His tag) fragment from the neuropeptide Y4 GPCR containing the N terminus, 
the first transmembrane domain (T1), the first intracellular loop (I1), the second 
transmembrane domain (T2), and the first extracellular loop  (E1) followed by a (His)6 
tag. This peptide (N-TM1-TM2) comprises about one third of the total length of the 
receptor (Fig. 1) and was obtained in multimilligram quantities. Importantly, the 
construct contains no fusion that needs to be removed after expression, and hence 
bypasses problems associated with chemical cleavage in the presence of residues like 
Met, or the enzymatic cleavage of hydrophobic sequences in the presence of detergents. 
Spectra with good quality could only be obtained when working under reducing 
conditions which eliminated fragment oligomerization. Detergent mixtures proved to be 
necessary to yield the high quality spectra required for our analyses. Using a 1-palmitoyl-
2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (LPPG)/dodecyl-phosphocholine 
(DPC) mixture and uniform 2H,13C,15N labeling, TROSY-based 3D triple-resonance 
spectra could be recorded that allowed almost complete assignment of the backbone 
nuclei. The secondary chemical shifts indicate that the peptide is largely helical except 
for a mostly unfolded N-terminal domain.  
4.2 Results 
4.2.1 Optimization of Protein Expression  
In order to obtain maximum expression of N-TM1-TM2 four different strains, 
BL21(DE3), C41(DE3) 55, BL21-AI and BL21-pLys(DE3), were evaluated. Amongst 
these BL21(DE3) is the most widely used expression host, while the other strains have 
been developed to express toxic proteins. Expression was tested for each strain at 37 °C 
and 20 °C. As shown in Fig. 2 temperature has a dramatic effect on the expression level 
of the target protein, which is significantly higher at 20 °C than at 37 °C. Although 
BL21(DE3) expresses the target protein at 20 °C, the reduced levels in comparison to the 
other strains that we tested indicates that the target protein may be toxic to this strain. 
Considering the perfect control of leakage expression, BL21-AI was chosen as the host 
for large-scale expression; nevertheless the difference in comparison to strains C41 or 
BL21pLys(DE3) is small.  
 
 
Figure 2: Selection of strain and expression conditions shown for BL21 and C41 (left) and for BL21-
AI and BL21 pLys (right). B denotes “before induction”, 37 denotes “induction at 37 °C” and 20 
denotes “induction at 20 °C”. 
 
The chosen construct comprises six cysteine residues, some of which will 
spontaneously form disulfide bonds, in particular in the presence of the divalent cation 
Ni2+. Protein preparations in both reducing and non-reducing sample buffer were 
analyzed by SDS-PAGE. It was observed that dimers, trimers and other oligomeric forms 
are observed in the non-reducing sample. Furthermore, we noticed the presence of a 
smear in the gel suggesting the occurrence of non-specific aggregation. Upon addition of 
100 mM DTT to the sample buffer the smearing disappeared and the oligomerization was 
dramatically reduced indicating that disulfide bond formation was responsible for 
aggregation.  
 
4.2.2 Optimization of Purification and Detergent 
 
The protein recovered after Ni affinity chromatography and treatment with DTT was 
fairly homogeneous as judged by SDS-PAGE. Nevertheless, the [15N,1H]-TROSY 
spectrum still displayed too few peaks, and peak intensities varied considerably. The 
latter characteristic is most likely due to conformational exchange processes. We 
reasoned that lipid components from the cell membrane or other hydrophobic impurities 
that co-elute with N-TM1-TM2 from the affinity column may result in a 
conformationally heterogeneous interaction/integration into the phospholipid micelles. 
Using this protein preparation we were unable to identify detergents that resulted in better 
spectra (vide infra). Accordingly the eluant from the Ni affinity column was subjected to 
C4 reverse-phase HPLC. The detrimental effects on spectral quality of contaminants 
remaining after Ni affinity chromatography have also been recently discussed by Page et 
al 56. The overall yield from a 1 L M9 culture of transformed BL-21AI cells after this 
additional step of chromatography was approximately 6 mg. We also noticed to our 
surprise that after lyophilization the solubility of the HPLC-purified protein in certain 
detergents had completely changed.  
In order to obtain resolved TROSY spectra with sharp peaks a number of detergents 
were screened, including anionic (SDS, sarcosyl, LPPG, LMPG), zwitterionic (DPC, 
DHPC, LDAO) and non-ionic (OGP, DDM) detergents, and proton-nitrogen correlation 
spectroscopy was used to assess the suitability of the resulting samples for structural 
studies. As shown in Fig. 3 different detergents resulted in vastly different spectra. In 
some detergents tested the target protein was insoluble. Spectra measured in most 
detergents that dissolved the protein were of poor quality in that most of the expected 
peaks were missing and that some lines were very broad (Fig. 3G and H). Spectra 
recorded in the presence of SDS micelles resulted in too many peaks albeit that they were 
very sharp (Fig. 3F). In addition, measurements of the 15N{1H}-NOE indicated that the 
protein was highly flexible.  
While the protein after elution from the Ni affinity column was nicely soluble in 200 mM 
LPPG solution, it turned out to be largely insoluble in the same detergent after the 
additional HPLC step. In contrast, it was now well soluble in DPC solution, a detergent in 
which the eluant from the Ni-affinity column was insoluble. Since it was observed that 
low-concentration samples prepared in LPPG resulted in good spectra, and considering 
the fact that DPC can solublize the protein well, we tested mixtures of these two 
detergents to exploit the individual advantages of both. First the minimal  
 
 
 
Figure 3: Plots of the two-dimensional [15N,1H]-HSQC spectra of N-TM1-TM2 recorded on 
samples of varying degrees of purity (spectra A to D) in various detergents (spectra E to H).  Spectra 
were recorded using 0.3mM samples of the protein at pH 6.0 in 200mM LPPG (A,B,D), 30mM DPC/ 
100mM LPPG (C), 150mM DPC (E), 170mM SDS (F), 170 mM OGP (G) and 100mM DHPC (H) at 
pH 6.0. The spectra on the left display protein samples directly after the Ni-affinity chromatography 
(A), after additional reduction with 100mM DTT and 250mM mercaptoethanol (B), after additional 
RP-HLPC in LPPG/DPC (C) and after purification and refolding using a method proposed by Page 
et al. 56 (D). The spectra on right were recorded with protein samples of highest purity and 
homogeneity. All data were recorded at 47 °C at 700 MHz proton frequency and the recognizable 
peak numbers out of the expected 115 are 74 (B), 109 (C), 97 (D), 63 (E), 161 (F), 12 (G), 15 (H), 
respectively, and is impossible to determine in (A).  
concentration of DPC required to dissolve at least 0.5 mM protein was determined. Then 
increasing amounts of LPPG were added to DPC until a good-quality spectrum was 
obtained, and no further chemical shift changes upon addition of more LPPG occurred. 
The final detergent mixture consisted of 6% LPPG and 1% DPC and was used in all 
subsequent studies. The TROSY spectra recorded on such a sample displayed rather 
uniform linewidths. In addition, the 15N{1H}-NOE data indicated that the backbone is 
rather rigid and that secondary structures are likely formed (see Fig. 6). Estimation of the 
overall correlation time derived from the 15N R2/R1 ratio resulted in a value of 11.4 ns at 
47°C. 
 
4.2.3 Spectroscopy and Backbone Assignment 
 
Considering the rather large molecular weight of the N-TM1-TM2/DPC/LPPG mixed 
micelle deuteration of the peptide was essential to yield spectra of sufficient quality. For 
backbone assignment a threefold strategy was pursued: i) matching of amide moieties via 
common Cab resonances in the HNCACB and HN(CO)CACB experiment, ii) matching 
via common CO frequencies in the HNCO and HN(CA)CO experiments, and iii) NOEs 
between sequential amide protons. Approx. 70% deuteration and the comparably narrow 
amide lines allowed for efficient TROSY-type triple resonance experiments. Alpha 
helical transmembrane proteins have intrinsically less signal dispersion and only 
constant-time 13C and 15N evolution in combination with mirror-image linear prediction 
provided sufficient resolution. Correlations in the triple-resonance HNCA and HNCACB 
spectra were observed for more than 80% of all residues. In the HNCO/HN(CA)CO pair 
correlations were almost always present. Representative strips from the assignment 
process are depicted in Fig. 4. Matching strips could be confirmed in the 15N-resolved 
NOESY for all residues within the helical region with sufficient resolution in the proton 
frequency. In the end all HN,N ,Ca and Cb nuclei could be assigned except for residues 
number 2 and 5, which are located in the flexible N terminal domain (see supplementary 
Table S3). Chemical shifts have been deposited in the BMRB database under accession 
code 15921. 
 
  
 
 
Figure 4: Plot displaying strips from the HNCACB (top), the HN(CA)CO (middle) and 15N-NOESY 
spectra for the TM segment comprising residues Val54 to Cys61. Only Cα  resonances are connected 
in the top panel. Strips were extracted at the 15N chemical shifts of the corresponding amide nitrogen. 
All data were recorded at 700 MHz at 47 °C using the 2H,13C,15N triply labeled protein in the 28 mM 
DPC/ 118 mM LPPG detergent mixture in 40 mM phosphate buffer, pH 6.0. 
 
4.2.4 Secondary Structure  
The CD spectrum of N-TM1-TM2 in DPC/LPPG mixed micelles is depicted in Fig. 
5. For technical reasons, 50uM polypeptide was used in comparison to 0.5mM in the 
NMR sample. However based on the NMR spectra no aggregation occurred at the higher 
concentration and we believe the data obtained from the CD and NMR study is 
comparable. The CD spectrum clearly shows the presence of minima at 208 and 222 nm, 
typical for predominantly alpha helical conformations. In addition, deconvolution of the 
CD spectrum into contributions from the different secondary structural elements using 
the program K2D (http://www.embl-heidelberg.de/~andrade/k2d/) allowed estimating the 
content in a-helix to be around 57%. The CD analysis indicates that secondary structure 
under these conditions is properly formed.  
 
 
 
Figure 5: CD spectrum of 50 mM N-TM1-TM2 recorded at 47 °C in 40 mM phosphate buffer (pH 
6.0) containing a mixture of 28 mM DPC and 118 mM LPPG. Data are converted to mean residue 
ellipticity. 
 
In order to verify the results from the CD analysis, we have evaluated the 15N{1H}-
NOE to derive information on the rigidity at residue resolution. The data are depicted in 
Fig. 6 and compared to structural and dynamical properties of the isolated N-terminal 
domain from the Y4 receptor recently determined by us in the presence of pure DPC 
micelles at pH 5.6 57. The latter structural studies revealed the presence of a short a-
helical stretch comprising residues 5 to 10, followed by a longer flexible loop in the 
segment between residues 11 and 25. Interestingly, the data on the construct described in 
this work indicated the presence of this flexible loop even when the N-terminal domain 
was fused to the first two helices. Otherwise the data indicate that with the exception of 
the N-terminal domain the protein is highly structured. Surprisingly, little difference in 
rigidity is observed between residues from the putative TM helices and the loops. In 
addition the long first extracellular loop (E1), that in our construct lacks its native 
connection to the third TM, is rather rigid. Amide hydrogen exchange as measured in a 
[15N,1H]-HSQC experiment with and without presaturation of the water resonance 
revealed accelerated exchange only for the N-terminus, for the long unstructured loop in 
the N-terminal domain (see supplementary Figure S2) and in vicinity to the charged 
residue within TM1. Surprisingly, even in the I1 or E1 loop, hydrogen exchange is 
relatively slow indicating that these segments are reasonably folded and/or protected 
from solvent access. 
 
 
Figure 6: Comparison of the 15N{1H}-NOE values for N-TM1-TM2 (black spheres) described in this 
work and the isolated N-terminal domain from the Y4 receptor (N-Y4, red diamonds). All values 
were measured on the 600 MHz spectrometer. Data of N-Y4 are taken from Zou et al57. 
 
Sidechain assignment is presently in progress, which will help establishing secondary 
structure based on characteristic medium-range NOEs. However, backbone 15N, Ca, Cb 
and C’ shifts have already been assigned and hence the location and type of secondary 
structure can be predicted based on secondary chemical shifts 58; 59. The output of the 
program TALOS 60 is depicted in Fig. 7. It predicts 74% of the 77 residue C-terminal 
fragment (the 2 TM helices plus the loops) to be helical. Interestingly, in both TM helices 
TALOS predictions indicate the TM helices to be destabilized adjacent to the internal 
polar residues Glu51and Thr52 in TM1 or Ser86 and Asp87 in TM2. Accordingly, no 
predictions were made for these regions. The locations of helical segments were also 
probed using proton,proton NOEs. In helices comparably short distances occur between 
sequential amide protons. Fig. 4 shows contacts within the segment encompassing 
residues Val54 to Cys61 that are consistent with such short distances. Comparably strong 
NOEs between sequential amide protons occur through most of the residues in the 
TM1/TM2 segments. Additionally they are observed for most of the residues from the I1 
and E1 loops. 
 
 
Figure 7: Summary of the 15N{1H}-NOE values for N-TM1-TM2 (bottom), predicted regions of 
helical structure based on 15N,13Cα β  and C’ chemical shifts using the program TALOS (middle)  and 
the presence of NOEs between sequential amide protons (top). Amide moieties displaying NOEs to 
both preceding and following residues are indicated by squares, and by triangles with the top to the 
left or right for those residues that only display contact to predecessors or successor, respectively. All 
segments with degeneracy of proton chemical shifts that does not allow identification of NOE cross 
peaks are indicated by crosses. 
4.3 Discussions 
Considering the tremendous difficulties encountered during expression, purification, 
reconstitution and the spectroscopic evaluation of entire GPCRs, new strategies to derive 
useful structural information are highly desired. Accordingly, in this work we developed 
synthetic approaches for a double-TM construct that additionally contains the N-terminal 
domain and the first extracellular loop.  
To our knowledge despite the success reported on the expression of polytopic 
bacterial membrane proteins56, most multiple-TM polypeptides from higher organisms 
have been expressed as fusion proteins followed by either enzymatic or chemical 
cleavage from their fusion partners. Enzymes used to release the hydrophobic membrane 
peptides are often deactivated by the detergents that are required to solubilize the 
expressed fusion proteins. Thus yields are poor and much material is wasted. Cyanogen 
bromide (CNBr) is usually the chosen reagent for chemical cleavage, but is incompatible 
with the occurrence of internal methionine residues, limiting its general usage. In this 
study a relatively long double-TM domain (approx. one third of the sequence of the entire 
receptor) from a human receptor was expressed without a fusion partner. This approach 
allowed expression of the wild-type protein sequence, eliminated the cleavage step, 
simplified purification and resulted in a final yield of six mg/L of culture. It should be 
noted that expression of entire GPCRs has been accomplished in various hosts, as fusion 
proteins as well as directly, and work in this area has been reviewed 61; 62. 
Purity and homogeneity are critical factors affecting the quality of NMR spectra. 
Considering that 15N-NH4Cl is comparably cheap and that [15N,1H]-TROSY spectra 
deliver a wealth of information on the state of the protein, we decided to monitor each 
step of purification using 15N,1H-correlation spectroscopy using only 15N-labeled protein. 
We noticed a number of interesting points: (1) The Ni-NTA affinity chromatography 
seemed to result in pure protein as visualized by SDS-PAGE, however the spectral 
quality from such samples was clearly insufficient (see supplementary Figure S1); (2) due 
to the presence of 6 cysteines, the protein was prone to forming aggregates that result in 
severe line broadening, and work-up under strongly reducing conditions was mandatory 
(see supplementary Figure S1); (3) the dramatic improvement after HPLC purification 
indicated the presence of non-proteinaceous contaminants, which cannot be readily 
removed by affinity chromatography. The chemical nature of the contaminants has not 
been identified so far, but we suspect them to be molecules that strongly associate with 
the protein so that they are not stripped off during the hydrophilic elution conditions of 
the affinity chromatography. This result suggests that they may be lipids or other 
hydrophobic components of the plasma membrane, that possibly also associate with the 
receptor in its natural environment. Another possibility is that they are proteins that bind 
to the metal affinity column. The presence of such contaminants apparently leads to 
heterogeneity in the microenvironment of the protein chains, in particular in the vicinity 
of the TM segments. This could affect the conformational exchange processes leading to 
the observed line-broadening. While HPLC purification is a standard technique for 
peptide chemists, it is often not used by protein biochemists because the solvent 
conditions denature most globular proteins. The possible presence of associating non-
proteinaceous or proteinaceous contaminants is relevant to crystallographers who usually 
judge protein purity from SDS-PAGE gels. Perhaps screening of sample purity by 15N,1H 
NMR, at least for some of the smaller membrane proteins systems, could prove useful 
prior to embarking on crystallization attempts. We are aware that the proposed procedure 
requires a refolding step. In the context of entire GPCRs such refolding may not be 
achieved easily. However, in literature precedents that such refolding is possible can be 
found 63; 64; 65. 
Membrane proteins can only properly exert their function when inserted in the 
membrane. Natural membranes, however, are characterized by the following features: 
they are patchy, with segregated regions of different chemical composition, variable 
thickness and distinct function 66. To mimic this environment various media have been 
developed such as detergent micelles 67, bicelles 68; 69; 70 amphipols 71; 72, and very 
recently nanoscale bilayers 73 (for a general review on the usage of detergents in NMR 
studies of membrane proteins see 74; 75; 76. For reasons of simplicity micelles have been 
frequently employed for NMR studies. In our study a wide range of detergents have been 
tested: Sarcosyl, LDAO, and DDM did not solubilize N-TM1-TM2. LPPG and LMPG 
only dissolved it to a very low extent, and others including DPC, OGP and DHPC 
dissolved the protein, but resulted in extremely broad spectra. Based on heteronuclear 
NOE analyses SDS resulted in a non-uniquely structured protein, an observation 
frequently also reported by other groups 67. The result of the detergent screening 
conducted in this study indicated that it may be useful to consider detergent mixtures 
when optimizing membrane protein solubility and integration into micelles. In the case of 
N-TM1-TM2 neither LPPG nor DPC gave satisfactory results, but the combination of 
these detergents resulted in a high-quality [15N,1H]-TROSY spectrum, in which 107 out 
of the expected 109 (without counting residues from the His-tag) peaks were observed. 
The final composition exhibited long-term stability and allowed us to run all of the three 
dimensional experiments required for a structural analysis. Natural membranes are 
heterogeneous mixtures of a variety of lipids and proteins. We suspect that various 
detergents can play different roles in solubilizing the peptide, aiding its integration into 
the lipid-like environment and forming a relatively stable composition. In the present 
example the LPPG head group is likely a much better mimic of head groups of naturally 
occurring lipids than DPC because the central glycerol component is retained. For 
reasons that are unclear to us at the moment, LPPG’s capability to spontaneously allow 
insertion of the N-TM1-TM2 protein is low and it does not solubilize the purified 
polypeptide. In contrast DPC micelles readily integrate the membrane protein but give 
extremely broad lines in the HSQC spectra, possibly reflecting the presence of 
conformational exchange. The ratio between DPC and LPPG was, therefore, chosen to 
represent the minimal amount of DPC required to dissolve the protein. The optimized 
composition gave a highly resolved HSQC spectrum perhaps indicating that LPPG-
peptide contacts are maximized in the TM region resulting in a relatively homogeneous 
microenvironment that led to good spectroscopic properties. By using a combination of 
detergents the number of membrane mimetic environments can be greatly increased and 
the possibility for trials that can exploit the synergistic contributions of different head 
groups and hydrophobic matches is maximized. It is important to note that protein 
detergent complexes are not idealized micelles and the insertion of detergents with 
different chain lengths at various positions in an asymmetric composition might, from a 
thermodynamic perspective, be predicted to lead to an optimally packed protein-lipid.  
Inspection of NOEs between sequential amide protons, and restraints from chemical 
shifts delivered by TALOS allowed the derivation of the first low-resolution picture of 
secondary structure in the N-TM1-TM2 polypeptide. Stretches of the putative TM helices 
are predominantly helical (see Fig. 7). However, in the regions proximal to polar residues 
in the TMs (E and D in TM1 and TM2, respectively) the helices are destabilized, as 
judged by the reduction in the heteronuclear NOEs, by the TALOS predictions, by 
enhanced amide proton exchange and by the absence of contacts between sequential 
amide protons. Buried glutamic acid and aspartic acid residues are rarely found in TM 
domains of integral membrane proteins, and we have noted such increased flexibility on 
another isolated TM domain in DPC micelles42. The biological significance of these 
findings will be subject to future work. A particularly interesting finding is, that the I1 
and E1 loops are predominantly helical. The sequence of the beginning of the I1 loop is 
amphiphilic, and may possibly form a surface-associated helix. The sequence of the E1 
loop is also amphiphilic in nature. In addition, it is rich in aromatic residues that are 
expected to position it in the interfacial compartment. Given the strong energetic driving 
force to place E1 in the interface compartment it is unlikely that E1 forms a flexible loop 
that diffuses into bulk solution. In the published crystal structures from rhodopsin 16 and 
the b-adrenergic receptors 20; 21, the long E2 loop contained elements of secondary 
structure; in the case of rhodopsin a short  b-sheet, in the case of the β1- and β2-
adrenergic receptors a-helices. However, the I1 and the E1 loops were devoid of regular 
secondary structure. Whether the helical nature of the E1 and I1 domains of N-TM1-TM2 
is biologically relevant awaits additional studies on larger Y4 receptor fragments. At 
present it is also unclear how the I1 and E1 helices would connect the TM helices and 
reinsert smoothly into the membrane. However, in GPCR structures published to date we 
note that the length of the TM helices is not generally conserved, e.g. the TM5 and TM6 
of squid rhodopsin were surprisingly deeply penetrating into the cytosol 18. 
Previously, we reported the conformational preferences of the isolated N-terminal 
domain in the presence of DPC micelles 57. The comparison of the dynamics data indicate 
that the latter and the corresponding fragment from the N-TM1-TM2 protein are highly 
similar in that they contain a short helix comprising residues 5 to 10, followed by a long 
and unstructured loop between residues 11 and 30. The segment that connects that loop to 
the first TM (residues 31 to 40) is rather flexible in the isolated N-Y4 peptide, but mostly 
helical in N-TM1-TM2. The amphiphilic sequence of the N-terminal region of N-TM1-
TM2 is compatible with the presence of a surface-associated helix. Such a helix was also 
observed by us on a similar construct from the Ste2p receptor, a family D GPCR from 
yeast (unpublished results). 
 
4.4 Conclusions 
To conclude we have developed a synthetic route for directly expressing and isolating 
double-domain mammalian GPCR fragment in isotopically-labelled form in good yield. 
Rigorous purification using a combination of affinity chromatography and reversed-phase 
HPLC resulted in a sample with dramatically altered biophysical properties. A rational 
method for NMR sample optimization is introduced that relies on mixtures of detergents.  
The methodology allowed the collection of good-quality 3D NMR spectra, and 
preliminary results indicated the protein to be highly structured in the LPPG/DPC mixed 
micelles. Future work will be aimed at fully establishing the secondary and tertiary 
structure of this important domain of human N-Y4. We believe that the presented 
methodology may also be useful in the studies of even larger fragments or entire 
receptors.  
4.5 Materials and methods 
4.5.1 Plasmid Construction 
The forward primer CGCGCTCATATGATGAACACCTCTCACCTCCTG, in 
which bold letters denote a NdeI cleavage site and the backward primer 
AGCGCGGGATCCTCAGTGATGGTGATGGTGATGCTTGCAGAGGGTCTCTCCA
AA, in which bold letters denote a BamHI cleavage site, italic letters the stop codon and 
underlined letters the 6xHis tag, were used to amplify the gene encoding N-TM1-TM2 
from the cDNA of the Y4 receptor (University of Missouri-Rolla, USA). The amplified 
gene was ligated into the plasmid pLC01 after both were cleaved with NdeI and BamHI 
and purified from agarose gel. The correctness of the recombinant DNA was confirmed 
by dideoxy sequencing (Synergene Biotech, Switzerland). 
 
4.5.2 Protein Expression and Purification 
The plasmid encoding the target protein was transformed into BL21-AI cells for 
expression, which were previously shown to result in higher expression levels compared 
to other strains 36. A freshly transformed colony was used to inoculate 10 ml LB 
containing 100 mg/ml ampicillin. This preculture was grown over night at 37 °C and was 
then used to inoculate 1L LB (for the unlabeled sample) or M9 (with 15NH4Cl and 13C 
glucose as sole nitrogen and carbon sources) media containing 100 mg/ml ampicillin and 
cultured at 37 °C until the OD600 reached 0.45-0.5. For induction the temperature was 
lowered to 20 °C and 0.2% L-arabinose was added. Cells were harvested after 12 hours 
and stored at –20 °C until further use. To allow expression in deuterated water 
transformed BL21-AI cells were plated on a D2O M9 agar plate, and one colony was used 
to inoculate a LB preculture in 100% D2O containing 100 mg/ml ampicillin. The 
preculture was grown at 37 °C overnight and was then used to inoculate 1L 95% D2O M9 
containing 75 mg/ml ampicillin. After incubation at 37°C overexpression was induced 
when the OD600 had reached 0.45 by adding 0.2% L-arabinose at 20 °C, and cells were 
harvested after 24 hours. 
The cell pellet from 1 L culture was resuspended in GdHCl-containing buffer and the 
target protein purified from inclusion bodies under denaturing conditions using Ni-
affinity chromatography.  The protein was incubated together with 100 mM DTT, 250 
mM mercaptoethanol, 10 mM EDTA at 4 °C over night to reduce any disulfide bonds. 
The reduced eluant was purified by C4 reverse-phase HPLC using a H2O/acetonitrile 
solvent system containing 0.1% TFA. The correctness of the target peptide was 
confirmed by MALDI-TOF (in case of unlabeled sample: 13645, theoretical mass: 
13647.9) as well as western blotting with anti-His antibody and N-terminal amino acid 
sequencing. The level of deuteration for the sample that was used for the backbone 
assignment was approx. 65% according to MS. Incomplete deuteration is solely due to 
back-exchange from labile protons and protons picked up from the non-deuterated 
glucose. 
 
4.5.3 NMR Sample Preparation 
1.7 mg 15N or 2H,13C,15N uniformly labeled protein was dissolved in 200 ml 
90%H2O/ D2O containing 2.5 mg DPC by thorough sonication and shaking at 37 °C for 
30 min. 15 mg LPPG were dissolved in 50 ml 0.2 mM phosphate buffer (pH 6.0), after 
which the two detergent solutions were mixed. The final concentration for each 
component in the final solution was as follows: 0.5 mM protein, 1% (28 mM) DPC, 6% 
(118 mM) LPPG, 10% D2O and 40 mM phosphate buffer (pH 6.0). The sample was 
stable for more than 2 months at 4 °C and more than 2 weeks at 47 °C.  
 
4.5.4 NMR Spectroscopy and Backbone Assignment  
All data were recorded on Avance 600 and 700 MHz Bruker spectrometers using 
triple-resonance cryoprobes at 47 °C. Chemical shifts of protons were calibrated 
according to the water line at 4.53 ppm at 47 °C, from which the carbon and nitrogen 
chemical shifts were referenced indirectly using the conversions factors published on the 
BMRB database. Sample optimization was conducted using solely 15N-labeled samples 
and [15N,1H]-TROSY spectroscopy 77. For backbone assignments standard Bruker 
experiments for the TROSY versions 78 of the 3D HNCACB 79; 80, HN(CO)CACB 79, 
HNCO 81 and HN(CA)CO 81 and a 200 ms 15N-NOESY were used. For the HNCACB or 
HN(CO)CACB experiments 1024(1H)*20(15N)*80(13C), for the HNCO or HN(CA)CO 
experiments 1024(1H)*20(15N)*32(13C), and for the 3D 15N-resolved NOESY 
1024(1H)*20(15N)*125(1H) complex data points were acquired. Spectral widths (and 
carrier positions) were 26 ppm (118.0 ppm) for 15N, 60 ppm for 13C in the experiments 
that label Ca and Cb resonances with the carbon carrier at 39 ppm for Cab and 54 ppm 
for Ca. In the HNCO-type experiments 20 ppm were used for carbon, with the carrier set 
to 176 ppm. All experiments used pulsed field gradients for water suppression 82, and the 
Kay-Palmer sensitivity enhancement trick 83 as incorporated into the TROSY sequences 
by Weigelt 84. A proton-detected version of the steady-state 15N{1H} heteronuclear 
Overhauser effect sequence was used for measurement of the heteronuclear NOE using a 
train of 120 degree proton pulses separated by 5 ms over a period of 3 seconds to achieve 
saturation of amide protons 85. 15N{1H}-NOEs were computed from the ratio of integrals 
from signals in the presence to those in the absence of amide proton irradiation. 
Spectra were processed within the Bruker spectrometer software Topspin 2.0. 
Backbone assignment was accomplished within the software CARA 86. Preferences for 
secondary structure based on 13Ca, 13Cb, 13CO and 15N chemical shifts were computed 
with the program TALOS 60. 
 
4.5.5 Circular Dichroism Spectroscopy 
CD spectra were recorded on Jasco model J-810 using 50 mM protein in 40 mM 
phosphate buffer (pH 6.0) in a mixture of 1% DPC and 6% LPPG in a quartz cuvette with 
a path length of 1 mm. All spectra were averaged from 3 consecutive measurements in 
the range between 190 and 250 nm at 47 °C with a slit width of 1nm and a scanning rate 
of 5 nm/min. The blank sample was recorded under identical conditions and subtracted 
from the sample spectra. The final CD intensity is expressed as the mean residue 
ellipticity (deg cm2 dmol-1). 
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4.8 Supplementary Materials 
 
 
Figures: S1: Aggregation for TM1-TM2 
 
 
 
 
 
 
 
Figure S2: Presaturation experiment: 
 
 
 
 
Table S3 Chemical shift of N-TM1-TM2-Y4 
 
No. Residue H N CA CB CO 
3 THR 8.502 116.704 64.639 68.049 175.956 
4 SER 8.297 117.174 61.182 62.11  
6 LEU 7.541 118.651 57.169 40.818 178.007 
7 LEU 7.824 116.372 57.203 40.259 178.092 
8 ALA 7.431 118.379 53.659 17.352 179.231 
9 LEU 7.319 116.245 56.134 41.323 177.463 
10 LEU 7.352 115.795 55.042 42.384 175.882 
11 LEU 7.336 116.954 52.441 40.46 174.681 
13 LYS 8.211 120.489 55.169 32.156 176.35 
14 SER 8.163 117.305 55.913 63.147 173.046 
16 GLN 8.235 119.338 55.489 28.446 176.399 
17 GLY 8.14 109.486 44.86  174.064 
18 GLU 8.118 120.26 56.033 29.231 176.105 
19 ASN 8.292 118.881 52.891 38.159 174.891 
20 ARG 8.087 121.063 55.578 29.724 175.979 
21 SER 8.158 116.689 57.852 63.693 173.757 
22 LYS 7.993 123.056 53.762 31.71 174.26 
24 LEU 8.099 120.823 54.763 41.43 177.019 
25 GLY 8.042 108.218 44.654  173.293 
26 THR 7.822 114.31 59.277 68.975 173.156 
28 TYR 7.73 118.795 57.613 38.16 174.899 
29 ASN 8.086 119.892 52.539 37.743 175.384 
30 PHE 8.113 121.307 59.609 38.722 176.702 
31 SER 8.225 114.721 60.226 62.833 175.609 
32 GLU 7.85 120.867 57.44 28.538 177.125 
33 HIS 7.831 115.255 55.926 28.369 175.614 
34 CYS 7.956 118.697 60.705 27.006 175.257 
35 GLN 8.248 120.432 57.827 27.72 176.773 
36 ASP 8.113 118.158 55.651 39.767 177.393 
37 SER 7.797 114.924 61.304 63.068 175.333 
38 VAL 7.798 121.908 65.628 30.682 176.829 
39 ASP 8.08 119.262 56.611 39.228 178.94 
40 VAL 7.717 119.968 65.61 30.696 177.133 
41 MET 7.834 118.844 58.492 31.117 177.828 
42 VAL 8.409 118.005 66.193 30.847 178.527 
43 PHE 7.972 121.986 60.701 37.947 177.557 
44 ILE 8.253 119.943 64.547 36.878 177.638 
45 VAL 8.1 114.911 64.891 30.67 176.856 
46 THR 7.736 107.996 63.125 69.177 175.815 
47 SER 7.486 116.533 60.129 63.251 173.66 
48 TYR 7.513 119.947 57.3 38.891 174.547 
49 SER 7.996 114.635 57.196 64.313 175.532 
50 ILE 8.668 123.423 63.026 36.645 176.94 
51 GLU 8.527 119.58 59.329 27.728 179.185 
52 THR 7.736 116.742 65.512 68.076 176.22 
53 VAL 7.675 120.84 66.226 30.679 177.119 
54 VAL 8.366 117.993 66.304 30.539 178.266 
55 GLY 7.853 107.714 46.592  176.326 
56 VAL 7.824 121.858 65.569 30.632 178.171 
57 LEU 8.181 119.129 57.552 40.384 179.287 
58 GLY 8.615 106.718 47.107  175.71 
59 ASN 7.753 120.101 55.856 37.98 177.852 
60 LEU 8.223 120.884 57.618 40.632 178.803 
61 CYS 8.253 117.607 63.741 26.203 176.421 
62 LEU 7.779 118.724 57.244 40.254 179.732 
63 MET 8.021 119.473 58.33 31.962 177.828 
64 CYS 7.88 116.525 62.913 26.804 175.883 
65 VAL 7.788 116.707 65.039 30.796 177.477 
66 THR 7.812 114.599 65.039 68.594 176.237 
67 VAL 7.85 120.146 64.688 30.548 176.854 
68 ARG 7.831 119.629 57.561 28.783 177.026 
69 GLN 7.846 117.188 57.086 27.852 177.34 
70 LYS 7.903 119.125 57.185 31.888 177.399 
71 GLU 8.139 117.887 56.43 28.092 176.762 
72 LYS 7.951 120.119 57.557 31.378 176.943 
73 ALA 8.009 122.21 52.929 17.831 177.742 
74 ASN 8.017 116.734 53.932 38.031 176.59 
75 VAL 8.101 119.059 64.495 30.794 176.585 
76 THR 7.937 114.408 65.352 67.953 175.438 
77 ASN 7.933 118.552 55.01 37.823 176.631 
78 LEU 7.664 120.124 56.61 41.235 177.914 
79 LEU 7.748 118.737 56.825 40.967 177.916 
80 ILE 7.748 115.977 62.554 37.006 176.982 
81 ALA 7.726 121.253 53.177 17.982 178.009 
82 ASN 7.648 114.432 53.546 39.12 174.909 
83 LEU 7.713 121.071 55.624 41.242 177.014 
84 ALA 8.026 122.608 52.829 17.628 178.085 
85 PHE 7.832 116.965 58.715 38.221 176.416 
86 SER 8.013 114.77 60.676 62.804 175.522 
87 ASP 8.107 121.944 56.714 39.495 178.197 
88 PHE 7.93 120.164 60.276 38.171 176.854 
89 LEU 7.876 118.322 57.193 40.554 178.23 
90 MET 7.946 115.666 57.389 30.773 178.358 
91 CYS 7.678 117.566 61.858 26.084 176.489 
92 LEU 7.523 119.597 57.08 40.879 176.955 
93 LEU 7.541 113.374 55.777 41.017 177.303 
94 CYS 7.463 113.246 60.09 27.666 175.267 
97 LEU 8.131 117.315 56.787 39.982 178.197 
98 THR 7.656 112.816 65.312 68.215  
99 ALA 7.805 124.299 54.592 17.593 178.848 
100 VAL 7.664 116.162 65.607 30.546 177.032 
101 TYR 7.939 118.513 59.883 36.748 177.758 
102 THR 7.909 114.942 65.878 68.552 176.027 
103 ILE 7.801 120.128 64.101 36.779 177.296 
104 MET 8.011 117.727 58.19 31.58 177.495 
105 ASP 7.978 118.206 56.131 39.54 177.742 
106 TYR 7.862 118.423 59.975 37.529 177.029 
107 TRP 8.19 120.39 59.408 28.847 176.828 
108 ILE 7.786 117.441 62.928 36.541 177.551 
109 PHE 7.666 119.482 59.212 38.067 177.289 
110 GLY 8.122 107.674 46.379  174.728 
111 GLU 8.246 120.011 57.799 27.902 177.57 
112 THR 7.774 113.838 64.716 68.348 175.617 
113 LEU 7.848 121.518 56.756 40.886 178.085 
114 CYS 7.807 115.664 60.692 26.926 175.433 
115 LYS 7.8 119.058 57.202 31.471 176.86 
116 HIS 7.882 116.16 55.42 28.445 174.38 
117 HIS 7.943 117.91   173.812 
 
 
